MTFR2 and hepatocellular carcinoma: Additionally, tumor tissues from mice injected with HCC alone or co‐injected with MTFR2‐deficient HSCs displayed fewer Ki67‐positive cells compared to those co‐injected with WT HSCs (Figure 6E and Figure S21B, Supporting Information).